{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:20:50Z","timestamp":1787800850379,"version":"build-2784847793"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/100006483","name":"AbbVie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006483","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10620-026-09952-0","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:36:25Z","timestamp":1778668585000},"page":"4318-4328","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pancrelipase Improves Symptoms of Exocrine Pancreatic Insufficiency and Health-Related Quality of Life in a Real-World Population of Patients with Chronic Pancreatitis"],"prefix":"10.1007","volume":"71","author":[{"given":"Mohamed O.","family":"Othman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J.","family":"Kort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell L.","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas A.","family":"Gonda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Lara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Jazrawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Keihanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R.","family":"Brett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diala","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guru","family":"Trikudanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"key":"9952_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/CEG.S168266","volume":"12","author":"G Capurso","year":"2019","unstructured":"Capurso G, Traini M, Piciucchi M, Signoretti M, Arcidiacono PG. Exocrine pancreatic insufficiency: Prevalence, diagnosis, and management. Clin Exp Gastroenterol. 2019;12:129\u2013139. https:\/\/doi.org\/10.2147\/CEG.S168266.","journal-title":"Clin Exp Gastroenterol."},{"key":"9952_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2023.943649","volume":"11","author":"Y Zheng","year":"2023","unstructured":"Zheng Y, Mostamand S. Nutrition in children with exocrine pancreatic insufficiency. Front Pediatr. 2023;11:943649. https:\/\/doi.org\/10.3389\/fped.2023.943649.","journal-title":"Front Pediatr."},{"key":"9952_CR3","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1097\/mpa.0000000000001137","volume":"47","author":"M Min","year":"2018","unstructured":"Min M, Patel B, Han S et al. Exocrine pancreatic insufficiency and malnutrition in chronic pancreatitis: Identification, treatment, and consequences. Pancreas. 2018;47:1015\u20131018. https:\/\/doi.org\/10.1097\/mpa.0000000000001137.","journal-title":"Pancreas."},{"key":"9952_CR4","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1097\/MPA.0b013e31824abb4d","volume":"41","author":"SN Duggan","year":"2012","unstructured":"Duggan SN, O\u2019Sullivan M, Hamilton S, Feehan SM, Ridgway PF, Conlon KC. Patients with chronic pancreatitis are at increased risk for osteoporosis. Pancreas. 2012;41:1119\u20131124. https:\/\/doi.org\/10.1097\/MPA.0b013e31824abb4d.","journal-title":"Pancreas."},{"key":"9952_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/mpa.0000000000002460","author":"JA Barkin","year":"2025","unstructured":"Barkin JA, Al-Kaade S, Pannala R et al. Protocol and study population of a prospective study of patients with chronic pancreatitis and exocrine pancreatic insufficiency: Preliminary findings from the PACT-CP registry show reduced health-related quality of life. Pancreas. 2025. https:\/\/doi.org\/10.1097\/mpa.0000000000002460.","journal-title":"Pancreas."},{"key":"9952_CR6","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1056\/NEJM197304192881603","volume":"288","author":"EP DiMagno","year":"1973","unstructured":"DiMagno EP, Go VL, Summerskill WH. Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med. 1973;288:813\u2013815. https:\/\/doi.org\/10.1056\/NEJM197304192881603.","journal-title":"N Engl J Med."},{"key":"9952_CR7","doi-asserted-by":"publisher","unstructured":"Whitcomb DC, Duggan SN, Martindale R, et al. AGA-pancreasfest joint symposium on exocrine pancreatic insufficiency. Gastro Hep Adv. 2023;2:395\u2013411. https:\/\/doi.org\/10.1016\/j.gastha.2022.11.008","DOI":"10.1016\/j.gastha.2022.11.008"},{"key":"9952_CR8","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1097\/MPA.0000000000000237","volume":"43","author":"DL Conwell","year":"2014","unstructured":"Conwell DL, Lee LS, Yadav D et al. American pancreatic association practice guidelines in chronic pancreatitis: Evidence-based report on diagnostic guidelines. Pancreas. 2014;43:1143\u20131162. https:\/\/doi.org\/10.1097\/MPA.0000000000000237.","journal-title":"Pancreas."},{"key":"9952_CR9","doi-asserted-by":"publisher","unstructured":"Othman MO, Harb D, Barkin JA. Introduction and practical approach to exocrine pancreatic insufficiency for the practicing clinician. Int J Clin Pract. 2018;72(2). https:\/\/doi.org\/10.1111\/ijcp.13066","DOI":"10.1111\/ijcp.13066"},{"key":"9952_CR10","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/j.pan.2022.03.013","volume":"22","author":"FEM de Rijk","year":"2022","unstructured":"de Rijk FEM, van Veldhuisen CL, Besselink MG et al. Diagnosis and treatment of exocrine pancreatic insufficiency in chronic pancreatitis: An international expert survey and case vignette study. Pancreatology. 2022;22:457\u2013465. https:\/\/doi.org\/10.1016\/j.pan.2022.03.013.","journal-title":"Pancreatology."},{"key":"9952_CR11","doi-asserted-by":"publisher","unstructured":"Gardner TB, Adler DG, Forsmark CE, Sauer BG, Taylor JR, Whitcomb DC. ACG clinical guideline: Chronic pancreatitis. Am J Gastroenterol. 2020;115:322\u2013339. https:\/\/doi.org\/10.14309\/ajg.0000000000000535","DOI":"10.14309\/ajg.0000000000000535"},{"key":"9952_CR12","doi-asserted-by":"publisher","unstructured":"Dominguez-Mu\u00f1oz JE, Vujasinovic M, de la Iglesia D, et al. European guidelines for the diagnosis and treatment of pancreatic exocrine insufficiency: UEG, EPC, EDS, ESPEN, ESPGHAN, ESDO, and ESPCG evidence-based recommendations. United European Gastroenterol J. 2025;13:125\u2013172. https:\/\/doi.org\/10.1002\/ueg2.12674","DOI":"10.1002\/ueg2.12674"},{"key":"9952_CR13","unstructured":"AbbVie Inc. Creon\u00ae. pancrelipase delayed-release capsules [Internet]. 2022."},{"key":"9952_CR14","unstructured":"Acare. Pancreatic exocrine insufficiency questionnaire: Abbott; Available from: https:\/\/acare.abbott.com\/en\/digestive-health\/pei-q\/."},{"key":"9952_CR15","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s40271-017-0233-0","volume":"10","author":"CD Johnson","year":"2017","unstructured":"Johnson CD, Arbuckle R, Bonner N et al. Qualitative assessment of the symptoms and impact of pancreatic exocrine insufficiency (PEI) to inform the development of a patient-reported outcome (PRO) instrument. The patient. 2017;10:615\u2013628. https:\/\/doi.org\/10.1007\/s40271-017-0233-0.","journal-title":"The patient."},{"key":"9952_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.pan.2018.11.013","volume":"19","author":"CD Johnson","year":"2019","unstructured":"Johnson CD, Williamson N, Janssen-van Solingen G et al. Psychometric evaluation of a patient-reported outcome measure in pancreatic exocrine insufficiency (PEI). Pancreatology. 2019;19:182\u2013190. https:\/\/doi.org\/10.1016\/j.pan.2018.11.013.","journal-title":"Pancreatology."},{"key":"9952_CR17","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1365-2036.2012.05202.x","volume":"36","author":"V Thorat","year":"2012","unstructured":"Thorat V, Reddy N, Bhatia S et al. Randomised clinical trial: The efficacy and safety of pancreatin enteric-coated minimicrospheres (CREON 40000 mms) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis\u2013a double-blind, placebo-controlled study. Aliment Pharmacol Ther. 2012;36:426\u2013436. https:\/\/doi.org\/10.1111\/j.1365-2036.2012.05202.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9952_CR18","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.1038\/ajg.2010.201","volume":"105","author":"DC Whitcomb","year":"2010","unstructured":"Whitcomb DC, Lehman GA, Vasileva G et al. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial. Am J Gastroenterol. 2010;105:2276\u20132286. https:\/\/doi.org\/10.1038\/ajg.2010.201.","journal-title":"Am J Gastroenterol."},{"key":"9952_CR19","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1038\/ajg.2017.42","volume":"112","author":"JD Machicado","year":"2017","unstructured":"Machicado JD, Amann ST, Anderson MA et al. Quality of life in chronic pancreatitis is determined by constant pain, disability\/unemployment, current smoking, and associated co-morbidities. Am J Gastroenterol. 2017;112:633\u2013642. https:\/\/doi.org\/10.1038\/ajg.2017.42.","journal-title":"Am J Gastroenterol."},{"key":"9952_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.pan.2018.02.012","volume":"18","author":"S Han","year":"2018","unstructured":"Han S, Patel B, Min M et al. Quality of life comparison between smokers and non-smokers with chronic pancreatitis. Pancreatology. 2018;18:269\u2013274. https:\/\/doi.org\/10.1016\/j.pan.2018.02.012.","journal-title":"Pancreatology."},{"key":"9952_CR21","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1002\/bjs.9146","volume":"100","author":"JW Park","year":"2013","unstructured":"Park JW, Jang JY, Kim EJ et al. Effects of pancreatectomy on nutritional state, pancreatic function and quality of life. Br J Surg. 2013;100:1064\u20131070. https:\/\/doi.org\/10.1002\/bjs.9146.","journal-title":"Br J Surg."},{"key":"9952_CR22","unstructured":"Acare Pro. Pancreatic exocrine insufficiency questionnaire: Abbott; 2023. Available from: https:\/\/acarepro.abbott.com\/tools\/pei-q\/."},{"key":"9952_CR23","unstructured":"Intro to promis\u00ae: Health Measures; 2021. Available from: https:\/\/www.healthmeasures.net\/explore-measurement-systems\/promis\/intro-to-promis."},{"key":"9952_CR24","doi-asserted-by":"publisher","first-page":"920","DOI":"10.3109\/00365529709011203","volume":"32","author":"SJ Lewis","year":"1997","unstructured":"Lewis SJ, Heaton KW. Stool form scale as a useful guide to intestinal transit time. Scand J Gastroenterol. 1997;32:920\u2013924. https:\/\/doi.org\/10.3109\/00365529709011203.","journal-title":"Scand J Gastroenterol."},{"key":"9952_CR25","unstructured":"Promis score cut points: HealthMeasures; Available from: https:\/\/www.healthmeasures.net\/score-and-interpret\/interpret-scores\/promis\/promis-score-cut-points."},{"key":"9952_CR26","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1097\/mpa.0000000000001733","volume":"50","author":"JA Barkin","year":"2021","unstructured":"Barkin JA, Barkin JS. Effect of pancrelipase therapy on exocrine pancreatic insufficiency symptoms and coefficient of fat absorption associated with chronic pancreatitis. Pancreas. 2021;50:176\u2013182. https:\/\/doi.org\/10.1097\/mpa.0000000000001733.","journal-title":"Pancreas."},{"key":"9952_CR27","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1097\/mpa.0000000000002423","volume":"54","author":"JA Barkin","year":"2025","unstructured":"Barkin JA, Kort JJ, Barkin JS. Pancrelipase delayed-release capsules improve stool frequency and consistency in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: Posthoc analysis of patient-reported daily symptoms in a double-blind randomized trial. Pancreas. 2025;54:e278\u2013e280. https:\/\/doi.org\/10.1097\/mpa.0000000000002423.","journal-title":"Pancreas."},{"key":"9952_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.2147\/tcrm.s3196","volume":"5","author":"DM Krishnamurty","year":"2009","unstructured":"Krishnamurty DM, Rabiee A, Jagannath SB, Andersen DK. Delayed release pancrelipase for treatment of pancreatic exocrine insufficiency associated with chronic pancreatitis. Therapeutics and clinical risk management. 2009;5:507\u2013520. https:\/\/doi.org\/10.2147\/tcrm.s3196.","journal-title":"Therapeutics and clinical risk management."},{"key":"9952_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.pan.2015.10.015","volume":"16","author":"MA Anderson","year":"2016","unstructured":"Anderson MA, Akshintala V, Albers KM et al. Mechanism, assessment and management of pain in chronic pancreatitis: Recommendations of a multidisciplinary study group. Pancreatology. 2016;16:83\u201394. https:\/\/doi.org\/10.1016\/j.pan.2015.10.015.","journal-title":"Pancreatology."},{"key":"9952_CR30","first-page":"2032","volume":"92","author":"A Brown","year":"1997","unstructured":"Brown A, Hughes M, Tenner S, Banks PA. Does pancreatic enzyme supplementation reduce pain in patients with chronic pancreatitis: A meta-analysis. Am J Gastroenterol. 1997;92:2032\u20132035.","journal-title":"Am J Gastroenterol."},{"key":"9952_CR31","doi-asserted-by":"publisher","first-page":"8541839","DOI":"10.1155\/2016\/8541839","volume":"2016","author":"M Yaghoobi","year":"2016","unstructured":"Yaghoobi M, McNabb-Baltar J, Bijarchi R, Cotton PB. Pancreatic enzyme supplements are not effective for relieving abdominal pain in patients with chronic pancreatitis: Meta-analysis and systematic review of randomized controlled trials. Can J Gastroenterol Hepatol. 2016;2016:8541839. https:\/\/doi.org\/10.1155\/2016\/8541839.","journal-title":"Can J Gastroenterol Hepatol."},{"key":"9952_CR32","doi-asserted-by":"publisher","first-page":"392","DOI":"10.3109\/00365529509093296","volume":"30","author":"A Malesci","year":"1995","unstructured":"Malesci A, Gaia E, Fioretta A et al. No effect of long-term treatment with pancreatic extract on recurrent abdominal pain in patients with chronic pancreatitis. Scand J Gastroenterol. 1995;30:392\u2013398. https:\/\/doi.org\/10.3109\/00365529509093296.","journal-title":"Scand J Gastroenterol."},{"key":"9952_CR33","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/MPA.0000000000000616","volume":"45","author":"J Romagnuolo","year":"2016","unstructured":"Romagnuolo J, Talluri J, Kennard E et al. Clinical profile, etiology, and treatment of chronic pancreatitis in North American women: Analysis of a large multicenter cohort. Pancreas. 2016;45:934\u2013940. https:\/\/doi.org\/10.1097\/MPA.0000000000000616.","journal-title":"Pancreas."},{"key":"9952_CR34","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/jgh.14783","volume":"35","author":"SS Olesen","year":"2020","unstructured":"Olesen SS, Kuhlmann L, Novovic S et al. Association of multiple patient and disease characteristics with the presence and type of pain in chronic pancreatitis. J Gastroenterol Hepatol. 2020;35:326\u2013333. https:\/\/doi.org\/10.1111\/jgh.14783.","journal-title":"J Gastroenterol Hepatol."},{"key":"9952_CR35","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.pan.2011.12.010","volume":"12","author":"EC Sikkens","year":"2012","unstructured":"Sikkens EC, Cahen DL, van Eijck C, Kuipers EJ, Bruno MJ. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: A Dutch National Survey. Pancreatology. 2012;12:71\u201373. https:\/\/doi.org\/10.1016\/j.pan.2011.12.010.","journal-title":"Pancreatology."},{"key":"9952_CR36","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1097\/MPA.0000000000001473","volume":"49","author":"MA Kempeneers","year":"2020","unstructured":"Kempeneers MA, Ahmed Ali U, Issa Y et al. Natural course and treatment of pancreatic exocrine insufficiency in a nationwide cohort of chronic pancreatitis. Pancreas. 2020;49:242\u2013248. https:\/\/doi.org\/10.1097\/MPA.0000000000001473.","journal-title":"Pancreas."},{"key":"9952_CR37","doi-asserted-by":"publisher","unstructured":"Erchinger F, Engjom T, Dimcevski G, et al. Exocrine pancreas insufficiency in chronic pancreatitis\u2014risk factors and associations with complications. A multicentre study of 1869 patients. Pancreatology. 2022;22:374\u2013380. https:\/\/doi.org\/10.1016\/j.pan.2022.02.003","DOI":"10.1016\/j.pan.2022.02.003"},{"key":"9952_CR38","doi-asserted-by":"publisher","first-page":"e63","DOI":"10.1097\/MCG.0000000000000917","volume":"52","author":"D de la Iglesia-Garcia","year":"2018","unstructured":"de la Iglesia-Garcia D, Vallejo-Senra N, Iglesias-Garcia J, Lopez-Lopez A, Nieto L, Dominguez-Munoz JE. Increased risk of mortality associated with pancreatic exocrine insufficiency in patients with chronic pancreatitis. Journal of clinical gastroenterology. 2018;52:e63\u2013e72. https:\/\/doi.org\/10.1097\/MCG.0000000000000917.","journal-title":"Journal of clinical gastroenterology."},{"key":"9952_CR39","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1111\/jgh.14460","volume":"34","author":"D de la Iglesia","year":"2019","unstructured":"de la Iglesia D, Vallejo-Senra N, Lopez-Lopez A et al. Pancreatic exocrine insufficiency and cardiovascular risk in patients with chronic pancreatitis: A prospective, longitudinal cohort study. J Gastroenterol Hepatol. 2019;34:277\u2013283. https:\/\/doi.org\/10.1111\/jgh.14460.","journal-title":"J Gastroenterol Hepatol."},{"key":"9952_CR40","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1111\/j.1365-2036.2011.04631.x","volume":"33","author":"N Gubergrits","year":"2011","unstructured":"Gubergrits N, Malecka-Panas E, Lehman GA et al. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (CREON) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery. Aliment Pharmacol Ther. 2011;33:1152\u20131161. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04631.x.","journal-title":"Aliment Pharmacol Ther."},{"key":"9952_CR41","doi-asserted-by":"crossref","unstructured":"Ware JE, Jr., Sherbourne CD. The mos 36-item short-form health survey (sf-36). I. Conceptual framework and item selection. Medical care. 1992;30:473\u2013483.","DOI":"10.1097\/00005650-199206000-00002"},{"key":"9952_CR42","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.pan.2013.01.009","volume":"13","author":"H Ramesh","year":"2013","unstructured":"Ramesh H, Reddy N, Bhatia S et al. A 51-week, open-label clinical trial in india to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis. Pancreatology. 2013;13:133\u2013139. https:\/\/doi.org\/10.1016\/j.pan.2013.01.009.","journal-title":"Pancreatology."},{"key":"9952_CR43","doi-asserted-by":"publisher","first-page":"1781","DOI":"10.1016\/j.cgh.2022.09.026","volume":"21","author":"D Yadav","year":"2023","unstructured":"Yadav D, Askew RL, Palermo T et al. Association of chronic pancreatitis pain features with physical, mental, and social health. Clin Gastroenterol Hepatol. 2023;21:1781-1791.e1784. https:\/\/doi.org\/10.1016\/j.cgh.2022.09.026.","journal-title":"Clin Gastroenterol Hepatol."},{"key":"9952_CR44","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1097\/MPA.0b013e31826532e7","volume":"42","author":"ST Amann","year":"2013","unstructured":"Amann ST, Yadav D, Barmada MM et al. Physical and mental quality of life in chronic pancreatitis: A case-control study from the North American pancreatitis study 2 cohort. Pancreas. 2013;42:293\u2013300. https:\/\/doi.org\/10.1097\/MPA.0b013e31826532e7.","journal-title":"Pancreas."},{"key":"9952_CR45","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1097\/MPA.0000000000000131","volume":"43","author":"JG D'Haese","year":"2014","unstructured":"D\u2019Haese JG, Ceyhan GO, Demir IE et al. Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: A 1-year disease management study on symptom control and quality of life. Pancreas. 2014;43:834\u2013841. https:\/\/doi.org\/10.1097\/MPA.0000000000000131.","journal-title":"Pancreas."},{"key":"9952_CR46","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1097\/mpa.0000000000001381","volume":"48","author":"JN Brownell","year":"2019","unstructured":"Brownell JN, Schall JI, Stallings VA. Pancreatic function in chronic pancreatitis: A cohort study comparing 3 methods of detecting fat malabsorption and the impact of short-term pancreatic enzyme replacement therapy. Pancreas. 2019;48:1068\u20131078. https:\/\/doi.org\/10.1097\/mpa.0000000000001381.","journal-title":"Pancreas."},{"key":"9952_CR47","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1111\/apt.15698","volume":"51","author":"CE Forsmark","year":"2020","unstructured":"Forsmark CE, Tang G, Xu H, Tuft M, Hughes SJ, Yadav D. The use of pancreatic enzyme replacement therapy in patients with a diagnosis of chronic pancreatitis and pancreatic cancer in the US is infrequent and inconsistent. Aliment Pharmacol Ther. 2020;51:958\u2013967. https:\/\/doi.org\/10.1111\/apt.15698.","journal-title":"Aliment Pharmacol Ther."}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09952-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-026-09952-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-026-09952-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T03:14:47Z","timestamp":1787800487000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-026-09952-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9952"],"URL":"https:\/\/doi.org\/10.1007\/s10620-026-09952-0","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MLR, SJ, and TAG have no relevant disclosures. DH, JJK, and ML are full-time employees of AbbVie Inc. and may hold AbbVie Inc. stock. TK serves as a consultant for ConMed, Lumendi, and Neptune Medical. LFL serves as a consultant and on a speakers bureau for AbbVie Inc. MOO serves as a consultant for AbbVie, Apollo, Boston Scientific Corporation, ConMed, Creo Medical, Lumendi, and Olympus and has received grant\/research support from AbbVie, Boston Scientific Corporation, ConMed, and Lucid Diagnostics. WP is a consultant and advisory committee\/board member for AbbVie, Ariel Medicine, Pfizer, Ionis, Horizon Therapeutics, and Nestle; a consultant for Acumen, Olympus, Arctx Medical, and Capsovision; and holds stock\/stock options in Arctx Medical.  NRB is an employee of PPD, part of Thermo Fisher Scientific, which was funded by AbbVie to conduct the analysis. GT serves as a consultant for Boston Scientific Corporation.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}